Literature DB >> 21595586

An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds.

Bui Huu Tai1, Nguyen Duy Nhut, Nguyen Xuan Nhiem, Tran Hong Quang, Nguyen Thi Thanh Ngan, Bui Thi Thuy Luyen, Tran Thu Huong, Jennifer Wilson, John A Beutler, Ninh Khac Ban, Nguyen Manh Cuong, Young Ho Kim.   

Abstract

CONTEXT: Acquired immune deficiency syndrome (AIDS) is a severe pandemic disease especially prevalent in poor and developing countries. Thus, developing specific, potent antiviral drugs that restrain infection by human immunodeficiency virus type 1 (HIV-1), a major cause of AIDS, remains an urgent priority.
OBJECTIVE: This study evaluated 32 extracts and 23 compounds from Vietnamese medicinal plants for their inhibitory effects against HIV-1 ribonuclease H (RNase H) and their role in reversing the cytopathic effects of HIV.
MATERIALS AND METHODS: The plants were air-dried and extracted in different solvent systems to produce plant extracts. Natural compounds were obtained as previously published. Samples were screened for RNase H inhibition followed by a cytopathic assay. Data were analyzed using the Microsoft Excel. RESULTS AND DISCUSSION: At 50 μg/mL, 11 plant extracts and five compounds inhibited over 90% of RNase H enzymatic activity. Methanol extracts from Phyllanthus reticulatus and Aglaia aphanamixis leaves inhibited RNase H activity by 99 and 98%, respectively, whereas four extracts showed modest protection against the cytopathic effects of HIV.
CONCLUSION: The screening results demonstrated that the butanol (BuOH) extract of Celastrus orbiculata leaves, methanol (MeOH) extracts of Glycosmis stenocarpa stems, Eurya ciliata leaves, and especially P. reticulatus leaves showed potential RNase H inhibition and protection against the viral cytopathic effects of HIV-1. Further chemical investigations should be carried out to find the active components of these extracts and compounds as potential anti-HIV drug candidates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21595586      PMCID: PMC3724220          DOI: 10.3109/13880209.2011.563316

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  14 in total

1.  Inhibitory effects of indirubin derivatives on the growth of HL-60 leukemia cells.

Authors:  Nguyen Manh Cuong; Bui Huu Tai; Dang Hoang Hoan; Tran Thu Huong; Young Ho Kim; Jae-Hee Hyun; Hee-Kyoung Kang
Journal:  Nat Prod Commun       Date:  2010-01       Impact factor: 0.986

2.  Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase.

Authors:  R S Fletcher; G Holleschak; E Nagy; D Arion; G Borkow; Z Gu; M A Wainberg; M A Parniak
Journal:  Protein Expr Purif       Date:  1996-02       Impact factor: 1.650

3.  Antiplasmodial activity of four Kenyan medicinal plants.

Authors:  E Omulokoli; B Khan; S C Chhabra
Journal:  J Ethnopharmacol       Date:  1997-04       Impact factor: 4.360

4.  Chrysoeriol isolated from the leaves of Eurya ciliata stimulates proliferation and differentiation of osteoblastic MC3T3-E1 cells.

Authors:  Bui Huu Tai; Nguyen Manh Cuong; Tran Thu Huong; Eun-Mi Choi; Jeong-Ah Kim; Young Ho Kim
Journal:  J Asian Nat Prod Res       Date:  2009-09       Impact factor: 1.569

5.  A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: compounds that compete with the template-primer.

Authors:  Carlos Cruchaga; Elena Anso; María Font; Virginia S Martino; Ana Rouzaut; Juan J Martinez-Irujo
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

6.  Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.

Authors:  Thiruvanmiyoor Ravichandran Kameswaran; Ravichandran Ramanibai
Journal:  Biomed Pharmacother       Date:  2008-04-09       Impact factor: 6.529

7.  Inhibition of normal lymphocyte proliferation by Indirubin-3'-monoxime: a multifactorial process.

Authors:  S Kagialis-Girard; V Mialou; A Chebel; W W Chien; I Tigaud; F Mokdad; C Badiou; M Ffrench
Journal:  Leuk Lymphoma       Date:  2007-03

8.  Antidiabetic potential of Phyllanthus reticulatus in alloxan-induced diabetic mice.

Authors:  S Kumar; D Kumar; R R Deshmukh; P D Lokhande; S N More; V D Rangari
Journal:  Fitoterapia       Date:  2007-08-11       Impact factor: 2.882

9.  New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity.

Authors:  O S Weislow; R Kiser; D L Fine; J Bader; R H Shoemaker; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1989-04-19       Impact factor: 13.506

10.  Chemical investigation of Phyllanthus reticulatus by HPLC-SPE-NMR and conventional methods.

Authors:  Sio-Hong Lam; Chen-Yu Wang; Chien-Kuang Chen; Shoei-Sheng Lee
Journal:  Phytochem Anal       Date:  2007 May-Jun       Impact factor: 3.373

View more
  4 in total

Review 1.  The Genus Phyllanthus: An Ethnopharmacological, Phytochemical, and Pharmacological Review.

Authors:  Xin Mao; Ling-Fang Wu; Hong-Ling Guo; Wen-Jing Chen; Ya-Ping Cui; Qi Qi; Shi Li; Wen-Yi Liang; Guang-Hui Yang; Yan-Yan Shao; Dan Zhu; Gai-Mei She; Yun You; Lan-Zhen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-20       Impact factor: 2.629

2.  The Stability of Medicinal Plant microRNAs in the Herb Preparation Process.

Authors:  Wenyan Xie; Matthias F Melzig
Journal:  Molecules       Date:  2018-04-16       Impact factor: 4.411

Review 3.  Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products.

Authors:  Ramandeep Kaur; Pooja Sharma; Girish K Gupta; Fidele Ntie-Kang; Dinesh Kumar
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

Review 4.  Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.

Authors:  Bahare Salehi; Nanjangud V Anil Kumar; Bilge Şener; Mehdi Sharifi-Rad; Mehtap Kılıç; Gail B Mahady; Sanja Vlaisavljevic; Marcello Iriti; Farzad Kobarfard; William N Setzer; Seyed Abdulmajid Ayatollahi; Athar Ata; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.